MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report
WASHINGTON and NEW YORK CITY and LONDON, April 1, 2015 /PRNewswire/ -- As a leading provider of market research reports and solutions, MarketResearch.com is pleased to highlight a report by BioInformant Worldwide, LLC, indicating that 2015 will be a year of market growth and opportunity for the stem cell industry.
For executives operating a stem cell company or cord blood bank, competing in the stem cell marketplace is a difficult task. You must analyze market conditions, predict industry trends, and act on market changes before the competition. Especially within the rapidly evolving stem cell marketplace, it can be difficult to make educated, informed decisions that produce revenue growth, while limiting failed products.
Therefore, MarketResearch.com is excited to announce that all research published by stem cell industry expert BioInformant Worldwide, LLC is available for 10% off during the month of April 2015. BioInformant specializes exclusively in stem cell market research and is the only research firm that has been tracking the market since it emerged.
To view all reports by BioInformant, visit http://www.marketresearch.com/land/publisher.asp?vendorid=3663&progid=87291.
Because there are hematopoietic stem cells in cord blood and mesenchymal stem cells in cord tissue, BioInformant has also been tracking the cord blood industry since 2006. One of BioInformant's most popular global strategic reports available through MarketResearch.com is the "Complete 2015-16 Global Cord Blood Banking Industry Report." To view this report, visit: http://www.marketresearch.com/land/product.asp?productid=8517835&progid=87291.
Published to assist company leaders and cord blood industry investors, this global cord blood report is designed to increase efficiency and effectiveness in:
- Communicating effectively with existing and potential clients
- Launching high-demand products and services
- Increasing revenue
- Taking market share from your competition
- Commercializing cord blood products, technologies, and therapies
- Making intelligent investment decisions
The global cord blood market has matured substantially over the past few years, creating both novel opportunities and serious threats. Serious threats to the industry include new accreditation requirements that have increased the cost structure of cord blood banks, a recent decline in cord blood transplants, low rates of turnover for stored cord blood units, difficulty with educating obstetricians about cellular therapies, and more. Marketing pressures are also impacting the industry, with the term "cord blood" becoming one of the 20 most expensive search terms on Google, reaching more than $20 per click for global search traffic and close to $40 per click for U.S. search traffic.
Additionally, awareness rates are limiting market potential. A study published in the Journal of Reproductive Medicine identified that a third of expectant parents are unaware of the option to preserve cord blood. Of the two-thirds who have some knowledge, 74% describe themselves as "minimally informed." A recent "Parent Survey" conducted by BioInformant Worldwide, LLC that incorporated 600+ responses from recent and expectant parents identified that awareness percentages have shifted little since the prior study was published.
However, there are also substantial opportunities for company executives who are positioned to take advantage of them, including the potential to expand the cord blood market through increased awareness, new clinical trial data supporting applications for hematopoietic stem cells (HSCs), improving public perception toward stem cell therapies, substantial deal-making within the industry, an industry trend toward diversified bio-banking, and much more.
Within the rapidly evolving stem cell marketplace, individuals who commit to understanding current opportunities and threats will be positioned for a substantial strategic advantage. Some stem cell companies and cord blood banks will make expensive new hires or a maintain business developments in an effort to compete, but you don't need to. For a much smaller investment, you can immediately make informed, educated decisions about your marketplace.
For a limited time only, we are offering a special 10% discount on any BioInformant report purchased at MarketResearch.com now through April 30, 2015. This exclusive offer is only available at MarketResearch.com. Enter discount code BI0410 at checkout to redeem.
To view all reports by BioInformant, visit: http://www.marketresearch.com/land/publisher.asp?vendorid=3663&progid=87291.
This publisher is also available on www.profound.com, where subscribers are able to purchase only the individual sections, chapters, tables or charts of a report they need without having to pay for the pieces they don't. April 2015 discount does not apply to BioInformant purchases on Profound, as content is already discounted.
About MarketResearch.com
MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance.
Connect with us on LinkedIn https://www.linkedin.com/company/marketresearch
Follow us on Facebook http://www.facebook.com/marketresearchdotcom
Follow us on Twitter http://www.twitter.com/marketresearch_
About BioInformant Worldwide
BioInformant specializes in global strategic reports for the stem cell industry and is the only research firm that has served the stem cell sector since it emerged. BioInformant research has been cited by prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, and more. In addition, BioInformant's management team comes from a "bioinformatics" background, the science of collecting and analyzing complex genetic codes. We are trained in applying these data analysis techniques to the field of market research. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, and Thermo Fisher Scientific, BioInformant is your trusted source of stem cell industry data.
MarketResearch.com
240.747.3008
[email protected]
Logo - http://photos.prnewswire.com/prnh/20140801/132627
SOURCE MarketResearch.com
Share this article